Takeda Pharma Maintains Outlook Even As Vyvanse Generics Hit Sales

benzinga.com/markets/earnings/25/07/46737233/takeda-pharma-maintains-outlook-even-as-vyvanse-generics-hit-sales

Takeda Pharmaceutical Company Limited (NYSE:TAK) posted a strong first-quarter performance for 2025 on Wednesday, with a net profit of 124.2 billion Japanese yen (approximately $834.08 million), reflecting a notable 30.4% year-over-year increase.
The company reported earnings per American…

This story appeared on benzinga.com, 2025-07-30 20:04:11.
The Entire Business World on a Single Page. Free to Use →